From Name:
From Email:
To Name:
To Email:

Optional Message:

Surgical oncologists find that chemotherapy is preferable to radiotherapy to reduce distant pancreatic cancer recurrences after surgery

from ACS

Study results suggest that patients with resectable pancreatic cancer should receive at least six months of adjuvant chemotherapy.
Patients who received chemotherapy after surgical resection of pancreatic cancer have fewer distant disease recurrences and longer overall survival than those who also had adjuvant chemoradiation therapy. While a course of radiotherapy in addition to chemotherapy and a cancer operation reduced the number of local disease recurrences, it did not affect distant recurrences or survival. Findings from the first multicenter clinical trial to relate disease recurrence patterns to the type of adjuvant therapy indicate that patients should receive a full course of chemotherapy rather than chemoradiotherapy following surgical treatment for pancreatic cancer. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063